Skip to main content

Advertisement

Log in

Surgical cure for type 2 diabetes by foregut or hindgut operations: a myth or reality? A systematic review

  • Review
  • Published:
Surgical Endoscopy Aims and scope Submit manuscript

Abstract

Background

Bariatric surgery results in remission of type 2 diabetes mellitus in a significant proportion of patients. Animal research has proposed the foregut and hindgut hypotheses as possible mechanisms of remission of T2DM independent of weight loss. These hypotheses have formed the basis of investigational procedures designed to treat T2DM in non-obese (in addition to obese) patients. The aim of this study was to review the procedures that utilise the foregut and hindgut hypotheses to treat T2DM in humans.

Methods

A systematic review was conducted to identify the investigational procedures performed in humans that are based on the foregut and hindgut hypotheses and then to assess their outcomes.

Results

Twenty-four studies reported novel procedures to treat T2DM in humans; only ten utilised glycated haemoglobin A1c (HbA1c) in their definition of remission. Reported remission rates were 20–40 % for duodenal–jejunal bypass (DJB), 73–93 % for duodenal–jejunal bypass with sleeve gastrectomy (DJB-SG), 62.5–100 % for duodenal–jejunal bypass sleeve (DJBS) and 47–95.7 % for ileal interposition with sleeve gastrectomy (II-SG). When using a predetermined level of HbA1c to define remission, the remission rates were lower (27, 63, 0 and 65 %) for DJB, DJB-SG, DJBS and II-SG.

Conclusions

The outcomes of the foregut- and hindgut-based procedures are not better than the outcomes of just one of their components, namely sleeve gastrectomy. The complexity of these procedures in addition to their comparable outcomes to a simpler operation questions their utility.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM et al (1995) Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 222(3):339–350; discussion 50–52

  2. Thaler JP, Cummings DE (2009) Minireview: hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology 150(6):2518–2525

    Article  CAS  PubMed  Google Scholar 

  3. Pok EH, Lee WJ (2014) Gastrointestinal metabolic surgery for the treatment of type 2 diabetes mellitus. World J Gastroenterol 20(39):14315–14328

    Article  PubMed  PubMed Central  Google Scholar 

  4. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ et al (2009) Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 122(3):248–256 e5

  5. Ikramuddin S, Korner J, Lee WJ, Connett JE, Inabnet WB, Billington CJ et al (2013) Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. JAMA 309(21):2240–2249

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L et al (2012) Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 366(17):1577–1585

    Article  CAS  PubMed  Google Scholar 

  7. Dixon JB, O’Brien PE, Playfair J, Chapman L, Schachter LM, Skinner S et al (2008) Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 299(3):316–323

    Article  CAS  PubMed  Google Scholar 

  8. Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE et al (2012) Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 366(17):1567–1576

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Patriti A, Aisa MC, Annetti C, Sidoni A, Galli F, Ferri I et al (2007) How the hindgut can cure type 2 diabetes. Ileal transposition improves glucose metabolism and beta-cell function in Goto-kakizaki rats through an enhanced Proglucagon gene expression and L-cell number. Surgery 142(1):74–85

    Article  PubMed  Google Scholar 

  10. Preitner F, Ibberson M, Franklin I, Binnert C, Pende M, Gjinovci A et al (2004) Gluco-incretins control insulin secretion at multiple levels as revealed in mice lacking GLP-1 and GIP receptors. J Clin Invest. 113(4):635–645

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Hansen EN, Tamboli RA, Isbell JM, Saliba J, Dunn JP, Marks-Shulman PA et al (2011) Role of the foregut in the early improvement in glucose tolerance and insulin sensitivity following Roux-en-Y gastric bypass surgery. Am J Physiol Gastrointest Liver Physiol 300(5):G795–G802

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Rubino F, Forgione A, Cummings DE, Vix M, Gnuli D, Mingrone G et al (2006) The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg 244(5):741–749

    Article  PubMed  PubMed Central  Google Scholar 

  13. Bose M, Olivan B, Teixeira J, Pi-Sunyer FX, Laferrere B (2009) Do Incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: what are the evidence? Obes Surg 19(2):217–229

    Article  PubMed  Google Scholar 

  14. Laferrere B (2011) Diabetes remission after bariatric surgery: is it just the incretins? Int J Obes (Lond) 35(Suppl 3):S22–S25

    Article  CAS  Google Scholar 

  15. World Health Organization (2000) Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organization technical report series, vol 894, pp i–vii, 1–253

  16. Lakdawala M, Bhasker A (2008) Report: Asian consensus meeting on metabolic surgery. recommendations for the use of bariatric and gastrointestinal metabolic surgery for treatment of obesity and type II diabetes mellitus in the Asian population: August 9th and 10th, 2008, Trivandrum, India. Obes Surg 20(7):929–936

    Article  Google Scholar 

  17. Buse JB, Caprio S, Cefalu WT, Ceriello A, Del Prato S, Inzucchi SE et al (2009) How do we define cure of diabetes? Diabetes Care 32(11):2133–2135

    Article  PubMed  PubMed Central  Google Scholar 

  18. Cohen R, Caravatto PP, Correa JL, Noujaim P, Petry TZ, Salles JE et al (2012) Glycemic control after stomach-sparing duodenal-jejunal bypass surgery in diabetic patients with low body mass index. Surg Obes Relat Dis 8(4):375–380

    Article  PubMed  Google Scholar 

  19. Huang C-K, Goel R, Tai C-M, Yen Y-C, Gohil VD, Chen X-Y (2013) Novel metabolic surgery for type II diabetes mellitus: loop duodenojejunal bypass with sleeve gastrectomy. Surg Laparosc Endosc Percutaneous Tech 23(6):481–485

    Article  Google Scholar 

  20. Klein S, Fabbrini E, Patterson BW, Polonsky KS, Schiavon CA, Correa JL et al (2012) Moderate effect of duodenal-jejunal bypass surgery on glucose homeostasis in patients with type 2 diabetes. Obesity (Silver Spring) 20(6):1266–1272

    Article  CAS  Google Scholar 

  21. Geloneze B, Geloneze SR, Chaim E, Hirsch FF, Felici AC, Lambert G et al (2012) Metabolic surgery for non-obese type 2 diabetes: incretins, adipocytokines, and insulin secretion/resistance changes in a 1-year interventional clinical controlled study. Ann Surg 256(1):72–78

    Article  PubMed  Google Scholar 

  22. Lee HC, Kim MK, Kwon HS, Kim E, Song KH (2010) Early changes in incretin secretion after laparoscopic duodenal-jejunal bypass surgery in type 2 diabetic patients. Obes Surg 20(11):1530–1535

    Article  PubMed  Google Scholar 

  23. Rodriguez-Grunert L, Galvao Neto MP, Alamo M, Ramos AC, Baez PB, Tarnoff M (2008) First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve. Surg Obes Relat Dis 4(1):55–59

    Article  PubMed  Google Scholar 

  24. Schouten R, Rijs CS, Bouvy ND, Hameeteman W, Koek GH, Janssen IM et al (2010) A multicenter, randomized efficacy study of the EndoBarrier Gastrointestinal Liner for presurgical weight loss prior to bariatric surgery. Ann Surg 251(2):236–243

    Article  PubMed  Google Scholar 

  25. Rodriguez L, Reyes E, Fagalde P, Oltra MS, Saba J, Aylwin CG et al (2009) Pilot clinical study of an endoscopic, removable duodenal-jejunal bypass liner for the treatment of type 2 diabetes. Diabetes Technol Ther 11(11):725–732

    Article  CAS  PubMed  Google Scholar 

  26. DePaula AL, Stival AR, DePaula CC, Halpern A, Vencio S (2012) Surgical treatment of type 2 diabetes in patients with BMI below 35: mid-term outcomes of the laparoscopic ileal interposition associated with a sleeve gastrectomy in 202 consecutive cases. J Gastrointest Surg 16(5):967–976

    Article  PubMed  Google Scholar 

  27. DePaula AL, Macedo AL, Mota BR, Schraibman V (2009) Laparoscopic ileal interposition associated to a diverted sleeve gastrectomy is an effective operation for the treatment of type 2 diabetes mellitus patients with BMI 21-29. Surg Endosc 23(6):1313–1320

    Article  CAS  PubMed  Google Scholar 

  28. DePaula AL, Stival AR, Halpern A, Vencio S (2011) Surgical treatment of morbid obesity: mid-term outcomes of the laparoscopic ileal interposition associated to a sleeve gastrectomy in 120 patients. Obes Surg 21(5):668–675

    Article  PubMed  Google Scholar 

  29. Kota SK, Ugale S, Gupta N, Naik V, Kumar KV, Modi KD (2012) Ileal interposition with sleeve gastrectomy for treatment of type 2 diabetes mellitus. Indian J Endocrinol Metab 16(4):589–598

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Kumar KV, Ugale S, Gupta N, Naik V, Kumar P, Bhaskar P et al (2009) Ileal interposition with sleeve gastrectomy for control of type 2 diabetes. Diabetes Technol Ther 11(12):785–789

    Article  PubMed  Google Scholar 

  31. Tinoco A, El-Kadre L, Aquiar L, Tinoco R, Savassi-Rocha P (2011) Short-term and mid-term control of type 2 diabetes mellitus by laparoscopic sleeve gastrectomy with ileal interposition. World J Surg 35(10):2238–2244

    Article  PubMed  Google Scholar 

  32. Cohen RV, Schiavon CA, Pinheiro JS, Correa JL, Rubino F (2007) Duodenal-jejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22–34 kg/m2: a report of 2 cases. Surg Obes Relat Dis 3(2):195–197

    Article  PubMed  Google Scholar 

  33. Ferzli GS, Dominique E, Ciaglia M, Bluth MH, Gonzalez A, Fingerhut A (2009) Clinical improvement after duodenojejunal bypass for nonobese type 2 diabetes despite minimal improvement in glycemic homeostasis. World J Surg 33(5):972–979

    Article  CAS  PubMed  Google Scholar 

  34. Ramos AC, Galvao Neto MP, de Souza YM, Galvao M, Murakami AH, Silva AC et al (2009) Laparoscopic duodenal-jejunal exclusion in the treatment of type 2 diabetes mellitus in patients with BMI <30 kg/m2 (LBMI). Obes Surg 19(3):307–312

    Article  PubMed  Google Scholar 

  35. de Moura EG, Martins BC, Lopes GS, Orso IR, de Oliveira SL, Galvao Neto MP et al (2012) Metabolic improvements in obese type 2 diabetes subjects implanted for 1 year with an endoscopically deployed duodenal-jejunal bypass liner. Diabetes Technol Ther 14(2):183–189

    Article  PubMed  Google Scholar 

  36. de Moura EG, Orso IR, da Martins BC, Lopes GS, de Oliveira SL, dos Galvao-Neto MP et al (2011) Improvement of insulin resistance and reduction of cardiovascular risk among obese patients with type 2 diabetes with the duodenojejunal bypass liner. Obes Surg 21(7):941–947

    Article  PubMed  Google Scholar 

  37. Escalona A, Pimentel F, Sharp A, Becerra P, Slako M, Turiel D et al (2012) Weight loss and metabolic improvement in morbidly obese subjects implanted for 1 year with an endoscopic duodenal-jejunal bypass liner. Ann Surg 255(6):1080–1085

    Article  PubMed  Google Scholar 

  38. Sandler BJ, Rumbaut R, Swain CP, Torres G, Morales L, Gonzales L et al (2011) Human experience with an endoluminal, endoscopic, gastrojejunal bypass sleeve. Surg Endosc 25(9):3028–3033

    Article  PubMed  Google Scholar 

  39. Raj PP, Kumaravel R, Chandramaliteeswaran C, Vaithiswaran V, Palanivelu C (2012) Laparoscopic duodenojejunal bypass with sleeve gastrectomy: preliminary results of a prospective series from India. Surg Endosc 26(3):688–692

    Article  PubMed  Google Scholar 

  40. Cohen RV, Neto MG, Correa JL, Sakai P, Martins B, Schiavon CA et al (2013) A pilot study of the duodenal-jejunal bypass liner in low body mass index type 2 diabetes. J Clin Endocrinol Metab 98(2):E279–E282

    Article  CAS  PubMed  Google Scholar 

  41. de Jonge C, Rensen SS, Koek GH, Joosten MF, Buurman WA, Bouvy ND et al (2013) Endoscopic duodenal-jejunal bypass liner rapidly improves plasma parameters of nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 11(11):1517–1520

    Article  PubMed  Google Scholar 

  42. Rubino F, Marescaux J (2004) Effect of duodenal–jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg 239(1):1

    Article  PubMed  PubMed Central  Google Scholar 

  43. Wang TT, Gao HD, Zhang GY, Liu CZ, Feng JB, Frezza EE (2008) Ileal transposition controls diabetes as well as modified duodenal jejunal bypass with better lipid lowering in a nonobese rat model of type II diabetes by increasing GLP-1. Ann Surg 247(6):968–975

    Article  PubMed  Google Scholar 

  44. Pacheco D, de Luis DA, Romero A, Sagrado MG, Conde R, Izaola O et al (2007) The effects of duodenal-jejunal exclusion on hormonal regulation of glucose metabolism in Goto-Kakizaki rats. Am J Surg 194(2):221–224

    Article  CAS  PubMed  Google Scholar 

  45. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP et al (2002) Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 346(21):1623–1630

    Article  PubMed  Google Scholar 

  46. Kotidis EV, Koliakos GG, Baltzopoulos VG, Ioannidis KN, Yovos JG, Papavramidis ST (2006) Serum ghrelin, leptin and adiponectin levels before and after weight loss: comparison of three methods of treatmen—a prospective study. Obes Surg 16(11):1425–1432

    Article  PubMed  Google Scholar 

  47. Van Citters GW, Lin HC (1999) The ileal brake: a fifteen-year progress report. Curr Gastroenterol Rep 1(5):404–409

    Article  PubMed  Google Scholar 

  48. Lin HC, Zhao X-T, Chu AW, Lin YP, Wang L (1997) Fiber-supplemented enteral formula slows intestinal transit by intensifying inhibitory feedback from the distal gut. Am J Clin Nutr 65(6):1840–1844

    CAS  PubMed  Google Scholar 

  49. Brown NJ, Worlding J, Rumsey R, Read N (1988) The effect of guar gum on the distribution of a radiolabelled meal in the gastrointestinal tract of the rat. Br J Nutr 59(02):223–231

    Article  CAS  PubMed  Google Scholar 

  50. Zhang G, Hasek LY, Lee B-H, Hamaker BR (2015) Gut feedback mechanisms and food intake: a physiological approach to slow carbohydrate bioavailability. Food Funct 6(4):1072–1089

    Article  CAS  PubMed  Google Scholar 

  51. Raybould HE (1998) Does your gut taste? Sensory transduction in the gastrointestinal tract. Physiology 13(6):275–280

    CAS  Google Scholar 

  52. Baskota A, Li S, Dhakal N, Liu G, Tian H (2015) Bariatric surgery for type 2 diabetes mellitus in patients with BMI <30 kg/m2: a systematic review and meta-analysis. PLoS ONE 10(7):e0132335

    Article  PubMed  PubMed Central  Google Scholar 

  53. Lee WJ, Almulaifi AM, Tsou JJ, Ser KH, Lee YC, Chen SC (2015) Duodenal-jejunal bypass with sleeve gastrectomy versus the sleeve gastrectomy procedure alone: the role of duodenal exclusion. Surg Obes Relat Dis 11(4):765–770

    Article  PubMed  Google Scholar 

  54. Rao WS, Shan CX, Zhang W, Jiang DZ, Qiu M (2015) A meta-analysis of short-term outcomes of patients with type 2 diabetes mellitus and BMI </= 35 kg/m2 undergoing Roux-en-Y gastric bypass. World J Surg 39(1):223–230

    Article  PubMed  Google Scholar 

  55. Abbatini F, Capoccia D, Casella G, Coccia F, Leonetti F, Basso N (2012) Type 2 diabetes in obese patients with body mass index of 30–35 kg/m2: sleeve gastrectomy versus medical treatment. Surg Obes Relat Dis 8(1):20–24

    Article  PubMed  Google Scholar 

  56. Lee WJ, Wang W, Lee YC, Huang MT, Ser KH, Chen JC (2008) Effect of laparoscopic mini-gastric bypass for type 2 diabetes mellitus: comparison of BMI >35 and <35 kg/m2. J Gastrointest Surg 12(5):945–952

    Article  PubMed  Google Scholar 

  57. Gill RS, Birch DW, Shi X, Sharma AM, Karmali S (2010) Sleeve gastrectomy and type 2 diabetes mellitus: a systematic review. Surg Obes Relat Dis 6(6):707–713

    Article  PubMed  Google Scholar 

  58. Gagner M (2011) Laparoscopic sleeve gastrectomy with ileal interposition (SGIT): a modified duodenal switch for resolution of type 2 diabetes mellitus in lesser obese patients (BMI <35). World J Surg 35(1):109–110

    Article  PubMed  Google Scholar 

  59. Schauer PR, Ikramuddin S, Gourash W, Ramanathan R, Luketich J (2000) Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg 232(4):515–529

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G et al (2003) Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 238(4):467–484; discussion 84–85

  61. Wittgrove AC, Clark GW (2000) Laparoscopic gastric bypass, Roux-en-Y-500 patients: technique and results, with 3-60 month follow-up. Obes Surg 10(3):233–239

    Article  CAS  PubMed  Google Scholar 

  62. Gill RS, Birch DW, Shi X, Sharma AM, Karmali S (2010) Sleeve gastrectomy and type 2 diabetes mellitus: a systematic review. Surg Obes Relat Dis 6(6):707–713

    Article  PubMed  Google Scholar 

  63. Abbatini F, Rizzello M, Casella G, Alessandri G, Capoccia D, Leonetti F et al (2010) Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes. Surg Endosc 24(5):1005–1010

    Article  CAS  PubMed  Google Scholar 

  64. Nocca D, Guillaume F, Noel P, Picot MC, Aggarwal R, El Kamel M et al (2011) Impact of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on HbA1c blood level and pharmacological treatment of type 2 diabetes mellitus in severe or morbidly obese patients. Results of a multicenter prospective study at 1 year. Obes Surg 21(6):738–743

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ravindra S. Date.

Ethics declarations

Disclosures

Yan Mei Goh, Zaher Toumi and Ravindra S. Date have no conflicts of interest or financial ties to disclose.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

Informed consent was not required as no participants were used in this study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Goh, Y.M., Toumi, Z. & Date, R.S. Surgical cure for type 2 diabetes by foregut or hindgut operations: a myth or reality? A systematic review. Surg Endosc 31, 25–37 (2017). https://doi.org/10.1007/s00464-016-4952-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00464-016-4952-4

Keywords

Navigation